• Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit

Helicobacter pylori (H. pylori) Antigen Rapid Test Kit

Fanttest brand rapid antigen test for Helicobacter pylori (H. pylori) enables quick and reliable detection of active H. pylori infections directly from stool samples. Results are available within 10 minutes, making it ideal for both clinical and point-of-care settings.

Fanttest Helicobacter pylori (H. pylori) Antigen Rapid Test Kit has obtained the listing certifiate from the Department of Health of Hong Kong, Listing No. #251451.

Fairview (HK) Technology Limited has been authorized as the OFFICIAL supplier of fanttest rapid test kits.

Welcome to contact us for a quote or to apply for a complimentary trial test kit.

Fanttest 品牌幽門螺旋桿菌(H. pylori)快速抗原檢測試劑,可透過糞便樣本快速、可靠地檢測出活性幽門螺旋桿菌感染。僅需10分鐘即可獲得結果,非常適合臨床及即場檢測場景使用。
Fanttest幽門螺旋桿菌(H. pylori)快速抗原檢測試劑已獲得香港衛生署認可並頒發註冊證書,證書表列號碼:HKMD#251451。

盛境(香港)科技有限公司是fanttest品牌病原體快速檢測試劑盒的官方授權供應商

歡迎聯繫我們獲取報價或申請免費試用試劑盒。

  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit
  • Helicobacter pylori (H. pylori) Antigen Rapid Test Kit

Description

What is Helicobacter pylori?
Helicobacter pylori (H. pylori) is a type of bacteria that colonizes the stomach and duodenum. It adheres to the stomach lining and produces urease, an enzyme that neutralizes stomach acid, allowing it to survive. Infection with this bacterium can lead to chronic gastritis, gastric ulcers, duodenal ulcers, and even increase the risk of stomach cancer.
A Recognized Carcinogen
The International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), classifies H. pylori as a Group 1 carcinogen, placing it in the same category as tobacco and alcohol, indicating sufficient evidence of its carcinogenicity to humans.
The U.S. Department of Health and Human Services (HHS) also lists chronic H. pylori infection as a known carcinogen.
Global Infection Status
Approximately 4.4 billion people worldwide are infected with H. pylori. Infection rates in Asia (including Hong Kong, mainland China, Japan, South Korea, etc.) exceed 50%.
A study by The Chinese University of Hong Kong indicates that local infection rates are similar to those in neighboring regions, reflecting the widespread prevalence of this bacterium in East Asia.
Symptoms of Infection
  • Early stage: May be asymptomatic or cause mild symptoms such as bloating, excessive gas, or loss of appetite, often mistaken for indigestion.

  • Long-term infection: About 10–15% of infected individuals develop gastric ulcers, experiencing stomach pain, vomiting blood, black stools (signs of gastrointestinal bleeding), or anemia.

Transmission Routes
H. pylori spreads primarily through saliva, shared utensils, or contaminated food and water. Transmission often occurs among family members or close contacts.
High-Risk Groups
  • People aged 40 and above

  • Smokers

  • Those with a family history of H. pylori infection or stomach cancer

  • Individuals with long-term diets high in salt, pickled, or smoked foods

H. pylori and Stomach Cancer
While stomach cancer has complex causes, H. pylori infection is a significant risk factor. It can trigger chronic gastritis, leading to gastric atrophy, intestinal metaplasia, and ultimately increasing the likelihood of cancer development.
Other high-risk factors for stomach cancer include:
  • Male gender (higher incidence)

  • Age over 50

  • Long-term poor dietary habits (e.g., high salt, low fiber)

  • Previous stomach surgery or gastric polyps

  • Family history of stomach cancer (risk increases more than twofold)

Testing and Treatment
  • H. pylori antigen test: Detects bacterial antigens in stool samples; fast and requires no fasting.

  • Positive result: Requires further medical consultation, typically treated with a combination of antibiotics.

  • Negative result: Indicates no current detection of infection, but continued monitoring is advised if symptoms persist.

Seek medical attention early if you experience persistent stomach discomfort, unexplained weight loss, or signs of gastrointestinal bleeding!

幽門螺旋菌是什麼?
幽門螺旋菌(Helicobacter pylori)是一種存活於胃部及十二指腸的細菌,能依附在胃黏膜上並分泌尿素酶,中和胃酸以利其生存。這種細菌感染可能導致慢性胃炎、胃潰瘍、十二指腸潰瘍,甚至增加患胃癌的風險。
公認的致癌物
國際癌症研究機構(IARC)(隸屬世界衞生組織)將幽門螺旋菌列為 第1組致癌物,與煙草、酒精同級,代表對人類致癌證據充分。
美國衞生及公共服務部(HHS) 亦將其慢性感染列入致癌物清單。
全球感染情況
全球約 44億人 感染幽門螺旋菌,亞洲地區(包括香港、中國內地、日本、韓國等)感染率超過 50%。
香港中文大學研究指出,本地感染率與鄰近地區相近,顯示此菌在東亞廣泛傳播。
感染後的症狀
初期:可能毫無症狀,或僅有輕微胃脹、胃氣多、食慾不振,易被誤認為普通消化不良。
長期感染:約 10-15% 患者會發展成胃潰瘍,出現胃痛、嘔血、黑便(消化道出血徵兆)或貧血。
傳播途徑
主要透過 唾液、共用餐具、受污染食物或水 傳播,常見於家庭成員或密切接觸者之間交叉感染。
高風險人群
40歲以上
有吸煙習慣
家族有幽門螺旋菌感染或胃癌病史
長期進食高鹽、醃製或燻製食物
幽門螺旋菌與胃癌的關係
胃癌成因複雜,但幽門螺旋菌感染是 重要風險因素之一。它可能引發慢性胃炎,逐步導致胃黏膜萎縮、腸化生,最終增加癌變機會。
胃癌的高危因素還包括:
男性(發病率較高)
年齡超過50歲
長期不良飲食習慣(如高鹽、低纖維)
曾接受胃部手術或患有胃息肉
家族胃癌病史(風險增2倍以上)
檢測與治療
幽門螺旋菌抗原測試:透過大便樣本檢測細菌抗原,快速且無需空腹。
陽性結果:需進一步就醫,通常以抗生素組合治療。
陰性結果:代表當前未檢測到感染,但如有症狀應持續監測。
若有持續胃部不適、無故消瘦或消化道出血症狀,應及早求診!